Results 151 to 160 of about 25,400 (245)

Rationalizing Proton Pump Inhibitor Use: Southeast Asia Consensus Recommendations

Journal of Gastroenterology and Hepatology, Volume 41, Issue 6, Page 1685-1700, June 2026.
ABSTRACT Background and Aim Proton pump inhibitors (PPIs) are integral to managing many gastrointestinal conditions. However, the prevalent inappropriate PPI prescription across Southeast Asia (SEA) is concerning. Given the absence of locally tailored recommendations to inform clinical practice, this consensus document aims to provide recommendations ...
Somchai Leelakusolvong, Tju Siang Chua, Duc Trong Quach, Andrew Ming‐Liang Ong, Ari Fahrial Syam, Augusto Jose G. Galang, Wee Kooi Cheah, Hang Viet Dao, Jose D. Sollano, Kalwinder Singh Khaira, Phuripong Kijdamrongthum, Rahela Ambaras Khan, Sakkarin Chirapongsathorn, Yeong Yeh Lee   +13 more
wiley   +1 more source

A Parallel Regulatory Pathway for New Microbial Technologies in China: Distinct From Drugs and Devices

Microbiota Medicine Research, Volume 1, Issue 2, Page 37-40, June 2026.
Rui Wang, Pan Li, Chen Lu, Faming Zhang
wiley   +1 more source

Development and Application of a Novel Dose–Response Model for the Quantification of Clostridioides difficile Infection Risks

Risk Analysis, Volume 46, Issue 6, June 2026.
ABSTRACT The lack of a dose–response model for Clostridioides difficile, attributed to insufficient human data, challenges effective C. difficile infection (CDI) risk management. This study presents a novel murine‐derived dose–response model for C.
Elizabeth N. Paddy, M. Sohail, Oluwasola O. D. Afolabi   +2 more
wiley   +1 more source

From Mask to Bed: Protective Barrier Containment and Rethinking the Prevention of Pathogen Transmission

Microbiota Medicine Research, Volume 1, Issue 2, Page 41-44, June 2026.
Quan Wen, Sheng Zhang, Qian Wang, Yuan Wu, Wei Hong, Juan Liao, Hon Ho Yu, Furu Wang, Yongzhan Nie, Faming Zhang   +9 more
wiley   +1 more source

In silico interaction of catalytic domain of Clostridioides difficile toxins TcdA and TcdB with some selected compounds from the SuperNatural 3.0 database

Kuwait Journal of Science
Clostridioides difficile is a pathogenic bacterium responsible for antibiotic-associated diarrhea globally. The pathogenesis of this bacterium is due to its virulence toxins, which inactivate the small GTPases from the Rho and Ras families in host cells,
doaj   +1 more source

Analysis of the impact of secondary prophylaxis on Clostridioides difficile recurrence in critically ill adults

, 2019
Introduction: Clostridioides (formerly Clostridium) difficile infection recurrence in patients re-exposed to antibiotics for treatment of a non-Clostridioides difficile infection is high at approximately 33%. Low-dose per os vancomycin (e.g. 125 mg q12 h)
Connor, Kathryn A, Conn, Kelly, Haas, Curtis E., Hatton-Kolpek, Jimmi   +3 more
core  

Characterization of Clostridioides strains and antibiotic resistance profile in Inflammatory Bowel Disease patients with Clostridioides infection

There is an increasing incidence of community-acquired Clostridioides difficile infection (CDI), particularly in IBD. Due to a suspected community outbreak in mid-2023, we aimed to investigate the microbiological and antibiotic resistance profile of CDI ...
Roseira, J., Sousa, H. Tavares de, Oliveira, R.   +2 more
core   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Effectiveness of fidaxomicin in preventing recurrence after initial community-associated <i>Clostridioides difficile</i> infection. [PDF]

Antimicrob Steward Healthc Epidemiol
Hawco A, Myers C, Dahhan R, Hurley C, van Wijngaarden E, Felsen C, Dumyati G.   +6 more
europepmc   +1 more source